EUVIMEDEUVIMED entdecken
Crossref

An assessment of cefiderocol's synergistic effects with eravacycline, colistin, meropenem, levofloxacin, ceftazidime/avibactam, and tobramycin against carbapenem-resistant and -susceptible Pseudomonas aeruginosa

Emel Mataracı-Kara, Bekir Özer, Mesut Yilmaz, Berna Özbek-Çelik

Microbial Pathogenesis · 2025-07 · 204 · 107560

DOI: 10.1016/j.micpath.2025.107560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Pathogenesis, 2025-07. Verfasst von Emel Mataracı-Kara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Microbiology, Faculty of Pharmacy University, 34116, Beyazit-Istanbul, Turkey. Electronic address: emataraci@istanbul.ed…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Pseudomonas aeruginosa, Cephalosporins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Istanbul Üniversitesi, Istanbul University Scientific Research Projects Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsPseudomonas aeruginosaCephalosporinsMicrobial Sensitivity TestsDrug SynergismColistinCeftazidimeMeropenemTobramycinLevofloxacinHumansDrug CombinationsAzabicyclo CompoundsCefiderocolPseudomonas InfectionsCarbapenemsBacterial Proteinsbeta-LactamasesDrug Resistance, Multiple, BacterialTetracyclines

Stichwörter der Autor:innen

Carbapenem-resistantCefiderocolCombinationPseudomonas aeruginosaSynergy

Substanzen

Anti-Bacterial AgentsColistinCeftazidimeMeropenemTobramycinavibactam, ceftazidime drug combinationLevofloxacinDrug CombinationsAzabicyclo CompoundsCefiderocol

Autor:innen und Institutionen

  • Department of Pharmaceutical Microbiology, Faculty of Pharmacy University, 34116, Beyazit-Istanbul, Turkey. Electronic address: emataraci@istanbul.edu.tr.
  • Department of Pharmaceutical Microbiology, Faculty of Pharmacy University, 34116, Beyazit-Istanbul, Turkey. Electronic address: bekirozer@istanbul.edu.tr.
  • Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Istanbul Medipol University, 34214, Istanbul, Turkey. Electronic address: myilmaz@medipol.edu.tr.
  • Department of Pharmaceutical Microbiology, Faculty of Pharmacy University, 34116, Beyazit-Istanbul, Turkey. Electronic address: berna.ozbek@istanbul.edu.tr.

Förderung

  • Istanbul Üniversitesi
  • Istanbul University Scientific Research Projects Unit

Zitieren

APA

Mataracı-Kara, E., Özer, B., Yilmaz, M., & Özbek-Çelik, B. (2025). An assessment of cefiderocol's synergistic effects with eravacycline, colistin, meropenem, levofloxacin, ceftazidime/avibactam, and tobramycin against carbapenem-resistant and -susceptible Pseudomonas aeruginosa. Microbial Pathogenesis, 204, 107560. https://doi.org/10.1016/j.micpath.2025.107560

Vancouver

Mataracı-Kara E, Özer B, Yilmaz M, Özbek-Çelik B. An assessment of cefiderocol's synergistic effects with eravacycline, colistin, meropenem, levofloxacin, ceftazidime/avibactam, and tobramycin against carbapenem-resistant and -susceptible Pseudomonas aeruginosa. Microbial Pathogenesis. 2025;204:107560. doi:10.1016/j.micpath.2025.107560

BibTeX
@article{MataracKara2025,
  author = {Mataracı-Kara, Emel and Özer, Bekir and Yilmaz, Mesut and Özbek-Çelik, Berna},
  title = {An assessment of cefiderocol's synergistic effects with eravacycline, colistin, meropenem, levofloxacin, ceftazidime/avibactam, and tobramycin against carbapenem-resistant and -susceptible Pseudomonas aeruginosa},
  journal = {Microbial Pathogenesis},
  year = {2025},
  volume = {204},
  pages = {107560},
  doi = {10.1016/j.micpath.2025.107560}
}
Kostenlos starten →